agilon health, inc.·4

Mar 11, 4:50 PM ET

Venkatachaliah Girish 4

4 · agilon health, inc. · Filed Mar 11, 2026

Research Summary

AI-generated summary of this filing

Updated

agilon health (AGL) CTO Girish Receives PSU Settlement

What Happened

  • Venkatachaliah Girish, Chief Technology Officer of agilon health, received 18,448 shares on March 9, 2026 upon the scheduled vesting/settlement of performance-based restricted stock units (PSUs). The filing shows 18,448 shares acquired (code P) via settlement (no cash purchase price reported).
  • To satisfy tax withholding obligations, the company withheld 6,477 shares (reported as a disposition, code F) at $0.60 per share, totaling $3,886. The withheld shares were not sold on the open market but retained by the issuer to cover taxes.

Key Details

  • Transaction date: March 9, 2026; Form 4 filed March 11, 2026 (appears timely within the two-business-day window).
  • Shares settled: 18,448 PSUs converted to common stock (no cash paid by the insider).
  • Tax withholding: 6,477 shares withheld at $0.60/share = $3,886. This is a remittance/withholding, not a market sale.
  • Vesting/award background: PSUs were granted April 14, 2023 and vested on March 9, 2026 based on 3-year performance goals; total attainment = 42% (see footnotes).
  • Shares owned after the transaction: not provided in the data supplied.
  • Footnotes summary: PSUs convert 1:1 to shares; vesting was performance-based (Revenue & Adjusted EBITDA, 2023–2025); net settlement includes withholding and includes restricted stock units.

Context

  • This was a scheduled PSU settlement (an award vesting), not an open-market purchase or a sale for cash. The withholding of shares to cover taxes is routine and should not be read as a market sale.
  • Performance achievement was 42% of target, so the vested amount reflects partial attainment of the original PSU goals.

Insider Transaction Report

Form 4
Period: 2026-03-09
Venkatachaliah Girish
Chief Technology Officer
Transactions
  • Purchase

    Common Stock

    [F1][F2][F3]
    2026-03-09+18,448285,084 total
  • Tax Payment

    Common Stock

    [F4][F5]
    2026-03-09$0.60/sh6,477$3,886278,607 total
Footnotes (5)
  • [F1]This award was granted on April 14, 2023 and all remaining performance-based restricted stock units (PSUs) subject to the award vested on March 9, 2026.
  • [F2]The number of PSUs that vested was determined based on agilon health's predetermined Revenue and Adjusted EBITDA goals over a three-year period from January 1, 2023 through December 31, 2025. Total attainment achieved was 42%.
  • [F3]Each PSU represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of PSUs in shares of common stock on their scheduled vesting date.
  • [F4]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent a sale.
  • [F5]Includes restricted stock units.
Signature
/s/ Mimi Yang, as Attorney-in-Fact|2026-03-11

Documents

1 file
  • 4
    wk-form4_1773262218.xmlPrimary

    FORM 4